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How adult neurons coordinate lipid metabolism to
regenerate axons remains elusive. We found that
depleting neuronal lipin1, a key enzyme controlling
the balanced synthesis of glycerolipids through the
glycerol phosphate pathway, enhanced axon regen-
eration after optic nerve injury. Axotomy elevated
lipin1 in retinal ganglion cells, which contributed to
regeneration failure in the CNS by favorably produc-
ing triglyceride (TG) storage lipids rather than phos-
pholipid (PL) membrane lipids in neurons. Regrowth
induced by lipin1 depletion required TG hydrolysis
and PL synthesis. Decreasing TG synthesis by delet-
ing neuronal diglyceride acyltransferases (DGATs)
and enhancing PL synthesis through the Kennedy
pathway promoted axon regeneration. In addition,
peripheral neurons adopted this mechanism for their
spontaneous axon regeneration. Our study reveals a
critical role of lipin1 and DGATs as intrinsic regula-
tors of glycerolipid metabolism in neurons and indi-
cates that directing neuronal lipid synthesis away
from TG synthesis and toward PL synthesis may
promote axon regeneration.
INTRODUCTION
Axon regeneration through modulating neuronal intrinsic mech-
anisms is a very promising strategy to develop potential thera-
pies for neural repair after CNS injury (Fawcett and Verhaagen,
2018; He and Jin, 2016; Liu et al., 2011; Mahar and Cavalli,
2018). Understanding the basic biological processes within neu-
rons that actively retard or enhance axon regrowth is becoming
increasingly important (Curcio and Bradke, 2018; Goldberg,Neuron 105, 1–17, J
This is an open access article und2003). Injured neurons require a large supply of lipids for mem-
brane formation as they grow long axons during regeneration
(Bradke et al., 2012; Pfenninger, 2009; Vance et al., 2000).
Many classes of lipids exist in neurons with various functions,
and not necessarily all lipids are crucial for axon growth. Thus,
axon regrowth requires coordinated changes in lipid homeosta-
sis in injured neurons. The metabolism of lipids such as fatty
acids and cholesterol has been actively studied in the brain (Ba-
zinet and Laye´, 2014; Pfrieger and Ungerer, 2011). Recent
studies in Drosophila larvae sensory neurons indicate that
neuronal lipid biosynthesis regulates dendritic complexity (Melt-
zer et al., 2017; Ziegler et al., 2017). However, relatively little is
known about how lipid metabolism is intrinsically regulated in
neurons to control axon elongation and regeneration.
Glycerolipids are abundant cellular lipids, including triglycer-
ides (TGs) for energy storage and phospholipids (PLs) for mem-
brane structure. Although TG molecules help organisms survive
starvation, they are not regarded as a major direct source of
energy for the brain (Scho¨nfeld and Reiser, 2013). However,
recent evidence suggests that neuronal TG lipases are very
active and that TGs undergo constant turnover in adult neurons
(Inloes et al., 2014). TG lipase hydrolyzes a TG to one fatty acid
and one diglyceride (DG). DGs are also a precursor of TGs and
PLs. Because PLs and TGs share common precursors, neurons
likely utilize this strategy to direct the flow of lipids toward
membrane production or energy storage depending on needs.
The glycerol phosphate pathway (glycerol 3-phosphate
pathway) is an important mechanism for controlling the glycero-
lipid levels in cells by regulating a series of enzymatic reactions.
Lipin1 protein, a phosphatidic acid phosphatase (PAP) enzyme,
plays a central role in the penultimate step of the glycerol phos-
phate pathway and catalyzes the conversion of phosphatidic
acid (PA) to DG (Han et al., 2006, 2007). In addition, lipin1 can
also regulate gene expression independent of its catalytic func-
tion by relocating to the nucleus and acting as a coregulator with
transcription factors (Finck et al., 2006).Mutation of lipin1 causes
lipodystrophy with almost complete loss of fat (Harris and Finck,anuary 22, 2020 ª 2019 The Author(s). Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. Lipin1 Depletion Promotes Axon Regeneration
(A) Quantification of the axon elongation by in vitro screening of glycerol-3-phosphate (G3P) metabolic genes in adult DRG neurons. We tested five genes
including lipin1, Gpat1, Agpat1, Agpat3, Agpat5. Gpat, Glycerol-3-phosphate acyltransferase. Agpat, 1-acyl-sn-glycerol-3-phosphate acyltransferase. Adult
(legend continued on next page)
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pathway, the final and only committed step is to form a TG by
covalently joining a fatty acyl-CoA and a DGmolecule. This reac-
tion is catalyzed by two acyl-CoA:diacylglycerol acyltransferase
(DGAT) enzymes, DGAT1 and DGAT2, both of which have been
implicated in modulating TG homeostasis (Yen et al., 2008). The
glycerol phosphate pathway is well characterized in tissues
specialized for energy storage or lipid turnover, such as adipose
tissue and liver. The function of this metabolic pathway in
neuronal response to injury and morphological change,
especially in regard to axon growth, has not been explored.
Neurons acquire lipid supplies either through uptake from the
external environment or de novo biosynthesis. Regardless of
where they are from, lipid building blocks must undergo meta-
bolic processes before they can be utilized by neurons for
various functions. We hypothesized that coordinated lipid meta-
bolism plays a role in axon regeneration. Here, we report that
neuronal lipin1 depletion promoted axon regeneration by regu-
lating glycerolipid metabolism. Axotomy elevated lipin1 in retinal
ganglion cells (RGCs), and this upregulation contributed to
regeneration failure. Lipin1 depletion promoted axon regrowth
by regulating TG hydrolysis and PL synthesis. Directly suppress-
ing TG biosynthesis also promoted axon regeneration and re-
programmed glycerolipid metabolism in the same direction as
lipin1 depletion. In contrast to RGCs, peripheral neurons down-
regulated DGAT1 upon axotomy, and TG hydrolysis was
required for axon regeneration after sciatic nerve injury. Thus,
we propose that TGs may provide lipid precursors to generate
PLs for membrane biosynthesis during axon regeneration and
that the glycerol phosphate pathway is a potential target for
neural repair.
RESULTS
Lipin1 Is an Intrinsic Suppressor of Axon Regeneration
To investigate the role of neuronal lipid metabolism in axon re-
growth, we systematically knocked down essential genes indi-
vidually using short hairpin RNA (shRNA) in cultured adult dorsal
root ganglion (DRG) neurons (Weng et al., 2018) (Figure S1A). We
tested candidates regulating the fatty acid metabolic process,
cholesterol synthesis, and glycerol phosphate pathway. Fatty
acids in the brain come from fatty acid uptake and synthesis.
Fatty acid translocase (CD36) transports long-chain fatty acids
through plasma membrane and has relatively high expressionDRG neurons were dissociated and transfected with the plasmids for 3 days. N
visualized by using Tuj1 staining. Three mice and 10–20 neurons from each mous
(B) Representative images of replated neurons from control shRNA and lipin1 sh
(C) Sections of optic nerves from WT mice at 2 weeks post-injury (WPI). The vitr
Axons were labeled by CTB-FITC. Scale bar: 100 mm.
(D) Number of regenerating axons at indicated distances distal to the lesion site.
(E) Sections of optic nerves from Rosa26-Cas9 mice at 2 WPI injected with eithe
(F) Number of regenerating axons at indicated distances from the lesion site. **p
(G) Sections of optic nerves from WT mice at 2 WPI injected with AAV-CNTF com
images are shown in the bottom panel. (G0) Zoomed-in images are shown in the bo
Arrows indicate regenerating axons in optic chiasm. Scale bar: 200 mm.
(H) Number of regenerating axons at indicated distances distal to the lesion site.
bars indicate SEM.
See also Figure S1.level in the brain (Husemann et al., 2002). The rate-limiting en-
zymes of fatty acid synthesis are acetyl CoA carboxylases
(ACC1 and ACC2) (Wakil, 1989). In the cholesterol synthesis
pathway, hydroxymethylglutaryl-CoA synthase (HMGCS) is the
most upstream enzyme. It catalyzes the reaction from acetyl
CoA to hydroxymethylglutaryl-CoA (HMG-CoA) (Bloch, 1965,
1992). The rate-limiting and reversible step in cholesterol synthe-
sis is the conversion of HMG-CoA to mevalonate by HMG-CoA
reductase (HMGCR) (Bloch, 1965, 1992). Another critical gene
in the pathway is squalene synthase (FDFT1). A previous report
has shown that Fdft1 is required for the neural development
(Tozawa et al., 1999). In the glycerol-3-phosphate pathway, glyc-
erol3-phosphate acyltransferase (GPAT) first converts glycerol-
3-phosphate to lysophosphatidic acid. Then 1-acylglycerol-3-
phosphate acyltransferase (AGPAT) catalyzes the conversion
from lysophosphatidic acid to phosphatidic acid. In the following
reaction, lipin converts phosphatidic acid to DG (Weiss et al.,
1960). We found that most shRNAs did not affect axon regrowth
in vitro (Figure S1B). Only lipin1 shRNA enhanced axon elonga-
tion by 20% (Figures 1A and 1B). Then, we used the optic nerve
injury model to assess the effect in vivo as previously described
(Leon et al., 2000) (Figure S1A). We injected adeno-associated
virus (AAV) carrying lipin1 shRNA (shLipin1) into the eyes of adult
wild-type (WT) mice to knock down lipin1 in RGCs (Figure S1C).
Then, we performed optic nerve crush and examined axon
regeneration 2 weeks later. The RGC survival rates were compa-
rable between the two groups (Figures S1D and S1E). Cholera
toxin b subunit (CTB) labeling of the optic nerves showed signif-
icantly more regenerated axons in mice injected with AAV-shLi-
pin1 than in mice injected with scrambled shRNA (shCtrl) (Fig-
ures 1C and 1D), suggesting that lipin1 plays an inhibitory role
in axon regeneration in vivo.
We next utilized the CRISPR technique to knock out lipin1 in
RGCs and assessed the effect. We designed single-guide
RNAs (sgRNAs) targeting lipin1 and CRISPR-induced genome
editing was verified in Neuro2A cells (Figure S1F). We injected
AAV-expressing sgRNAs targeting lipin1 (sgLipin1) with mCherry
tag into the eyes of mice constitutively expressing the Cas9
enzyme (Platt et al., 2014). The efficiency of in-vivo gene editing
was validated by qRT-PCR using fluorescence-activated cell
sorting (FACS)-isolated mCherry-positive retinal cells
(Table S2). We found that AAV-sgLipin1 but not AAV-expressing
sgRNA targeting LacZ (sgCtrl) promoted axon regeneration after
injection into Cas9 mice (Figures 1E and 1F). AAV-sgLipin1eurons were then replated and fixed 24 h after replating. DRG neurites were
e were quantified in each group. *p% 0.05, ANOVA followed by Dunnett’s test.
RNA groups with Tuj1 staining. Scale bar: 400 mm.
eous body was injected with either AAV-control-shRNA or AAV-lipin1-shRNA.
**p% 0.01, ANOVA followed by Bonferroni’s test, n = 6 mice.
r AAV-control-sgRNA or AAV-lipin1-sgRNA. Scale bar: 100 mm.
% 0.01, ANOVA followed by Bonferroni’s test, n = 6 mice.
bined with either AAV-control or lipin1-shRNA. Scale bar: 400 mm. Zoomed-in
ttompanel. Scale bar: 400 mm. (G00) Zoomed-in images of optic chiasm from (G).
**p% 0.01, *p% 0.05, ANOVA followed by Bonferroni’s test, n = 6 mice. Error
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and S1H). Consistent with the shRNA experiment, RGC survival
was not affected by lipin1 knockout (KO) (Figure S1I). We asked
whether lipin2, another member of the lipin protein family, plays a
role in the axon regeneration. By doing qRT-PCR in sorted
RGCs, we showed that lipin2 mRNA was not significantly
changed after lipin1 knockdown (KD) (Figure S1J). Then, we
used CRISPR to knock out lipin2 in RGCs and assessed the
growth effect after optic nerve crush. We found that lipin2 KO
did not promote significant regrowth and did not further enhance
axon regeneration induced by lipin1 KD (Figures S1K and S1L).
Our results suggest that lipin2 does not compensate for the
loss of lipin1 in mediating axon regeneration. Furthermore,
combining AAV-shLipin1 with AAV expressing ciliary neurotro-
phic factor (AAV-CNTF) (Pernet et al., 2013) achieved much
more robust growth (Figures 1G and 1H). Some axons even
reached the optic chiasm within 2 weeks, which was rare after
either treatment alone. Lipin1 KD may accelerate the speed of
CNTF-induced regeneration. Lipin1 KD also enhanced the
axon regeneration induced by Pten KO (Figures S1M and
S1N). To examine whether the extent of lipin1 KD is correlated
with the extent of axon regeneration, we made another AAV-ex-
pressing lipin1 shRNA2, different from the lipin1 shRNA we used
above. Lipin1-shRNA2 showed less KD efficiency compared to
the lipin1-shRNA (Figure S1O). The axon regeneration induced
by AAV-lipin1-shRNA2 was also consistently less (Figure S1P).
Thus, through two approaches in vivo, we demonstrated that
neuronal lipin1 functions as an intrinsic suppressor of axon
regeneration.
Lipin1 Is Selectively Regulated by Aging and Injury
in RGCs
Both aging and response to injury may mediate the intrinsic
growth decline of CNS neurons (Belin et al., 2015; Byrne et al.,
2014; Cho et al., 2015; Goldberg et al., 2002). We postulated
that lipid metabolism could be involved in the decline and exam-
ined lipin1 expression in RGCs at different ages and after optic
nerve injury. By performing immunostaining, we found that lipin1
protein in RGCs could hardly be detected in young mice but was
elevated in adults (Figures 2A and 2B), suggesting that matura-
tion may upregulate lipin1. Interestingly, the vast majority of
the aRGCs marked by the SMI32 antibody were lipin1+. Over
80% of aRGCs expressed a lower level of lipin1 (low lipin1+),
while the rest had a high expression level (high lipin1+). After op-
tic nerve crush, the percentage of high lipin1+ aRGCs increased
over 3-fold at 3 days post crush (dpc) (Figures 2C and 2D). In
contrast, we did not detect an evident change in the lipin1 level
in M1–M3 intrinsically photosensitive RGCs (ipRGCs) by using
Opn4-GFP mice (Figures S2A and S2B) (Li et al., 2016) or
RGCs labeled by TBR2 antibody (Figures S2C and S2D). Tbr2
is expressed in a subset of RGC types that project to non-im-
age-forming areas (Mao et al., 2014; Sweeney et al., 2014).
Thus, maturation and axonal injury selectively regulate lipin1
levels in RGCs
Based on the results, we examinedwhether the selective regu-
lation of lipin1 in injured aRGCs correlates with axon regenera-
tion. aRGCs have been shown to regenerate their axons
after Pten KO (Duan et al., 2015). To identify RGCs with axon4 Neuron 105, 1–17, January 22, 2020regeneration induced by lipin1 KD, we injected fluorogold (FG)
into the optic nerve distal to the lesion site. Over 89% of the
FG-labeled RGCswere aRGCswith SMI32 staining (Figure S2E).
Furthermore, we found that lipin1 elevation in injured aRGCswas
suppressed by either deleting Pten in RGCs or overexpressing
AAV-CNTF in the retina (Figures S2F and S2G), consistent with
the notion that lipin1 functions as an intrinsic inhibitor for RGCs
to regenerate the axons.
Lipin1 Suppresses Growth by Its Phosphatidate
Phosphatase Activity
Lipin1 has both PAP and transcription coactivator functions
(Finck et al., 2006), and we tested whether both functions
were involved in lipin1-dependent growth. The PAP catalytic
motif (DxDxT) is present in the C-LIP domain of lipin1, and con-
version of the first or second aspartate residue in the DxDxT
motif to glutamate completely abolishes PAP activity (Finck
et al., 2006). The coactivator function can be decoupled from
PAP function because mutations in the DxDxT motif abolish
PAP activity but do not affect coactivator function (Finck
et al., 2006). Thus, through AAVs, we expressed human WT
lipin1 (lipin1-WT), lipin1 with a PAP catalytic motif mutation
(lipin1-PAPm), and lipin1 lacking a nuclear localization signal
(lipin1-DNLS) in RGCs with lipin1 depletion (Figure 3A; Fig-
ure S3A). We designed shRNA to specifically KD mouse lipin1
and spare exogenous human lipin1. Lipin1-WT but not lipin1-
PAPm suppressed axon regeneration to the level of control
(Figures 3B and 3C), indicating that PAP activity rather than
transcription coactivator function was essential. The result
also confirmed that lipin1 shRNA-induced regeneration was
not due to potential off-target effects. Consistently, lipin1-
DNLS also significantly inhibited the growth effect caused by
lipin1 depletion (Figures 3B and 3C), suggesting that its nuclear
function was not required. RGC survival was not significantly
affected in the different groups (Figure S3B). To examine the
rescue effect in isolated neurons, we also performed an exper-
iment using adult DRG culture. Lipin1-WT and lipin1-DNLS but
not lipin1-PAPm inhibited axon elongation in neurons induced
by lipin1 KD (Figure S3C), consistent with our in vivo results.
Thus, through both in vitro and in vivo experiments, we were
able to conclude that the PAP activity of lipin1 plays a major
role in inhibiting axon regeneration.
Lipin1 Regulates Levels of TGs and PLs in Neurons
Because PAP activity is critical for lipin1-dependent axon
growth, we hypothesized that lipin1 may control axon regrowth
by regulating glycerolipid synthesis in neurons. In budding yeast
and mammalian metabolic cells including adipocytes and hepa-
tocytes, lipin1, as a PAP enzyme, plays a major role in lipid ho-
meostasis, especially in the balanced synthesis of TGs and
PLs (Pascual and Carman, 2013; Siniossoglou, 2013; Zhang
andReue, 2017).Whether this lipid homeostasis is similarly regu-
lated in neurons is not known. We tested the hypothesis in vitro.
AAV-shLipin1 or AAV-shCtrl was added to cultured cortical neu-
rons to achieve high KD efficacy (Table S1). We directly
measured glycerolipid levels after eliminating glial cells by add-
ing cytosine arabinoside (AraC) to the culture (Figure S3D). To
assess the change in the lipid profile in neurons after lipin1 KD,
Figure 2. Lipin1 Levels Are Upregulated during Development and after Axotomy
(A) Retinal sections fromWTmice of different ages (1, 7, 21, and 50 days postnatal) were collected and stainedwith DAPI (blue), Tuj1 (green), and lipin1 (red). Scale
bar: 10 mm.
(B) Percentage of RGCs with a low or high lipin1 level at the indicated ages. **p% 0.01, *p% 0.05, ns, not significant, ANOVA followed by Tukey’s test.
(C)Whole-mount retinas fromWTmice 3 days after axotomy or sham surgery were collected and stained for DAPI (blue), SMI32 (green), and lipin1 (red). Scale bar:
50 mm. Zoomed-in images are shown in the right panel. Scale bar: 10 mm.
(D) Percentage of aRGCs with a low or high lipin1 level indicated by lipin1 staining. **p% 0.01, ANOVA followed by Bonferroni’s test. Error bars indicate SEM.
See also Figure S2.
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pin1. Lipid extraction of cortical neurons was analyzed by
ultra-performance liquid chromatography-mass spectrometry
(UPLC-MS) system. We employed a non-targeted approach to
identify all the molecules that differ between the two groups.
Data were then analyzed by orthogonal partial least-squares
discriminant analysis (OPLS-DA) (Bylesjo et al., 2006). Among
all the differential molecules, 57 molecules were identified as dif-
ferential lipid species (p < 0.05 and variable importance for pro-
jection [VIP] >1) using lipid databases (Figure 3D). DGs/TGs and
PLs comprised 26%and 40%of all the differential lipids, respec-
tively, showing that the two metabolic pathways were highly
regulated by lipin1 in neurons. After lipin1 depletion, the levels
of TG(41:2) and TG(48:0), which were the most abundant among
the eight identified TGs, decreased 18% and 28%, respectively
(Figure S3E). The levels of the phosphatidylcholine (PC) lipids
PC(30:4) and PC(33:5), which were the most abundant among
the nine identified PCs, increased 17% and 15%, respectively
(Figure S3F). The levels of the phosphatidylethanolamine (PE)lipids PE(36:4) and PE(37:3), which were the most abundant
among the four identified PEs, increased 110% and 151%,
respectively (Figure S3G). Cholesterol and free fatty acid were
not significantly affected (Figure S3H). Because UPLC-MSmight
not identify all lipid molecular species, we further measured the
total TG and PC levels by performing enzymatic hydrolysis
assays. We found that TG levels were decreased by 40% after
lipin1 depletion (Figure 3E). Interestingly, PC levels were
elevated by 26% (Figure 3F). Thus, the two lipid assay methods
consistently demonstrated that, upon lipin1 depletion, storage
lipids were lower and membrane lipids were higher in neurons.
Because injury triggers lipin1 elevation in RGCs, the data on lipid
changes after lipin1 KD indicate that axotomy may program lipid
metabolism to increase TG and decrease PL production. This
injury-triggered bias in lipid synthesis may contribute to the
declined axon growth in CNS neurons. By depleting lipin1,
injured neurons may redirect two arms of the branch and
shift lipid storage to membrane lipid production for axon
regrowth.Neuron 105, 1–17, January 22, 2020 5
Figure 3. Lipin1 Inhibits Axon Regeneration through Its Phosphatidate Phosphatase Activity and Regulates Glycerolipid Metabolism in
Neurons
(A) Schematic representation of the different lipin1 overexpression constructs used for the subsequent experiments.
(B) Sections of optic nerves fromWT mice at 2 WPI, injected with AAV-lipin1-shRNA combined with AAV-GFP, AAV-lipin1-WT, AAV-lipin1-PAPm, or AAV-lipin1-
DNLS. Scale bar: 100 mm.
(C) Number of regenerating axons at different distances distal to the lesion site. **p% 0.01, *p% 0.05, ANOVA followed by Tukey’s test, n = 5–6 mice.
(D) Heatmap represents the alteration of lipidomes after lipin1 KD in cortical neurons. Lipid species with the top 20 VIP are listed. Colors correspond to differences
in relative abundance.
(E and F) Total TG (E) andPC (F) levels in cortical neurons after AAV-control or lipin1-shRNA treatment. **p% 0.01, *p% 0.05, Student’s t test. Error bars indicateSEM.
See also Figure S3.
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Figure 4. TG Hydrolysis Is Required for the Axon Regeneration Induced by lipin1 Depletion
(A) Schematic showing the TG metabolism pathway in mammals.
(B) Representative images of DRG neurons cultured with DMSO vehicle, Atglistatin, or KLH-45 for 3 days. BODIPY (green) staining was used to visualize lipid
droplet distribution in neurons. Scale bar: 20 mm.
(C) Sections of optic nerves from Rosa26-Cas9 mice with lipin1-sgRNA injection at 2 WPI combined with AAV-control or Atgl shRNA. Scale bar: 100 mm.
(D) Number of regenerating axons at different distances distal to the lesion site. **p% 0.01, ANOVA followed by Tukey’s test, n = 5–6 mice.
(legend continued on next page)
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Given that lipin1 regulates the amount of TG in neurons, we
asked whether neuronal TG metabolism was important for
axon growth induced by lipin1 depletion. TGs are often stored
in lipid droplets, which can rarely be detected in neurons. The
TG level in the brain is usually much lower than in other tissues
(Csaki et al., 2013). Two TG lipases, adipose TG lipase (ATGL)
and DDHD2, are active in the brain (Etschmaier et al., 2011; In-
loes et al., 2014), and they hydrolyze TGs to DGs and fatty acids
(Figure 4A). Knocking out Ddhd2 in mice causes large amounts
of TGs to accumulate in the brain and lipid droplets to form in
neurons (Inloes et al., 2014). Treating mice with a specific
DDHD2 inhibitor elevates brain TGs within a few days (Inloes
et al., 2014), indicating active TG hydrolysis in adult neurons.
We first performed experiments to manipulate TG lipases
in vitro. In cultured adult DRG neurons with vehicle treatment,
we could barely detect any lipid droplets (Figure 4B), consistent
with the notion that neurons constantly turn over TGs with mini-
mum storage. Either the ATGL inhibitor Atglistatin or the DDHD2
inhibitor KLH-45 dramatically increased TG storage in neurons,
as shown by lipid droplet formation (Figure 4B), indicating that
these inhibitors effectively targeted TG lipases. Then, we exam-
ined the function of TG lipases in axon regeneration in vivo. We
made AAVs carrying either Atgl shRNA (AAV-shAtgl) or Ddhd2
shRNA (AAV-shDdhd2) and verified the KD efficacy in vitro (Fig-
ures S4A–S4D). Then, we injected these AAVs into the eyes of
mice with lipin1 depleted in RGCs and examined the effect
2 weeks after optic nerve crush. Expression of each individual vi-
rus and the coefficiency of two viruses were validated by whole-
mount retina staining (Figure S4E; Table S3). AAV-shAtgl almost
completely blocked axon regeneration (Figures 4C and 4D).
AAV-shDdhd2 partially suppressed the regrowth (Figures 4E
and 4F). RGC survival was not affected by either shRNA (Figures
S4F and S4G). We further examined whether increasing TG syn-
thesis affects axon regeneration more generally. In mice with
AAV-CNTF injection into the eyes or Pten deletion in RGCs,
Atgl KD significantly suppressed the axon regeneration of the
optic nerves (Figures S4H–S4K). Thus, our data indicate that
TG hydrolysis is indispensable to the axon regeneration induced
not only by lipin1 depletion but also by CNTF or Pten KO.
Inhibiting TG Synthesis Promotes Axon Regeneration
Because we showed that TG hydrolysis was required, we
assessed whether directly decreasing the level of neuronal
TGs by restricting their biosynthesis can promote axon growth.
In the final step of the glycerol phosphate pathway, DGAT en-
zymes catalyze DGs into TGs. To assess the effect of blocking
the DGAT enzyme, we first used commercially available
DGAT1 inhibitors, A-922500 and pradigastat, in culture.
DGAT1 inhibitors enhanced the axon elongation of DRG neurons
by 60% (Figures S5A and S5B). Then, we performed a KD exper-
iment by transfecting Dgat1 shRNA (shDgat1) or Dgat2 shRNA
(shDgat2) into DRG neurons. Compared with control shRNA,(E) Sections of optic nerves from Rosa26-Cas9 mice with lipin1-sgRNA i
bar: 100 mm.
(F) Number of regenerating axons at different distances distal to the lesion site. p%
See also Figure S4.
8 Neuron 105, 1–17, January 22, 2020Dgat1 and Dgat2 shRNA both significantly boosted axon growth
(Figures S5C and S5D). Because axotomy increases lipin1
expression in RGCs, we wondered whether DGAT enzymes
were also regulated by axonal injury. Using the DGAT1 antibody,
we found that optic nerve injury elevated the level of DGAT1 in
RGCs at 3 dpc (Figures 5A and 5B). Furthermore, we deleted
DGATs in RGCs through CRISPR by injecting AAV-sgRNA
against Dgat1 (AAV-sgDgat1) or Dgat2 (AAV-sgDgat2) into the
eyes of Cas9 mice and assessed retinal axon regeneration after
optic nerve injury. CRISPR-induced genome editing was verified
in vitro (Figure S5E). Knocking out either Dgat1 or Dgat2
enhanced axon regeneration after injury without affecting RGC
survival (Figures 5C, 5D, and S5F). We then assessed the lipid
profile in cultured neurons with Dgat1 KD to evaluate whether
DGATs may affect the glycerolipids in neurons. All identified
TGs decreased after Dgat1 KD (Figure 5E). Two abundant PC
species PC(29:1) and PC(36:2) increased more than 8-fold
compared to the control shRNA group (Figure 5F). We then
determined the levels of TGs and PCs using lipid hydrolysis as-
says. Consistently, depleting DGAT1 or DGAT2 decreased the
TG level in neurons (Figure 5G). The PC content was increased
(Figure 5H). DGs, as a substrate for the DGAT reaction, are
also a substrate for PL synthesis. The glycerol phosphate
pathway may also provide DGs as an important precursor for
PLs. Our interpretation was that, with lipin1 elevation in injured
neurons, neuronal depletion of DGAT1 or DGAT2 might divert
DGs to the Kennedy pathway to increase PL synthesis. The
DGs may come from PA dephosphorylation and TG hydrolysis.
Then, we tested whether TG hydrolysis was required for
DGAT-dependent axon regeneration. We injected AAV-shAtgl
into the eyes of mice with Dgat1 or Dgat2 deleted in RGCs and
examined the optic nerve 2 weeks after nerve crush. AAV-shAtgl
dramatically suppressed the axon regeneration induced by
knocking out either Dgat (Figures 5I, S5G, and S5H). The data
indicate that inhibiting TG synthesis promotes axon regeneration
possibly by providing DGs for PL synthesis through TG hydroly-
sis. Consistent with the notion that lipin1 andDGAT1/2 are on the
same lipid synthesis pathway, combining lipin1 KD and Dgat1
KO did not further promote axon regeneration (Figure S5I).
Our data suggest that both lipin1 and DGATs are important in
determining the flux of lipids into TGs or PLs and the subsequent
axon regeneration. Thus, axotomy drives up two essential en-
zymes of the glycerol phosphate pathway in neurons, suggesting
the critical involvement of this lipid metabolic pathway in axon
regeneration failure after injury.
PL Biosynthesis Is Crucial for Axon Regeneration
Lipin1 depletion or mutation has been demonstrated to generate
net increases in PC in several types of cells (Santos-Rosa et al.,
2005; Zhang et al., 2012, 2014). This result may be counterintu-
itive because DGs, the product of the PAP reaction, are a direct
precursor of PC and PE. Several lines of evidence point to the
possibility that a reduction in PAP activity elevates PA levels,njection at 2 WPI combined with AAV-control or Ddhd2 shRNA. Scale
0.05, ANOVA followed by Tukey’s test, n = 5–6mice. Error bars indicate SEM.
Figure 5. TG Synthesis Inhibition Promotes Axon Regeneration
(A) Retinal sections from WT mice 3 days after injury or sham surgery were collected and stained for Tuj1 (green) and DGAT1 (red). Scale bar: 50 mm.
(B) Quantification of relative fluorescence intensity of DGAT1 staining in RGCs. *p% 0.05, Student’s t test, n = 5 mice.
(C) Sections of optic nerves from Rosa26-Cas9 mice at 2 WPI. The vitreous body was injected with AAV-control, Dgat1, or Dgat2-sgRNA. Axons were labeled by
CTB-FITC. Scale bar: 100 mm.
(D) Numbers of regenerating axons in (C) at indicated distances distal to the lesion site. **p% 0.01, ANOVA followed by Tukey’s test, n = 6 mice.
(E and F) Levels of individual TG (E) and PC (F) species normalized to the total protein from either Ctrl orDgat1-shRNA group. Themolecular species are indicated
as the total number of carbons: the number of double bonds. **p% 0.01, *p% 0.05, t test, n = 6.
(legend continued on next page)
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https://doi.org/10.1016/j.neuron.2019.10.009and subsequently PAmay stimulate PCYT1, a critical enzyme for
PC synthesis, leading to an increase in PC production (Craddock
et al., 2015; Zhang et al., 2019). As two of the major building
blocks of membranes, PC and PE are predicted to be essential
during axon regrowth. However, disruption ofPcyt1b only gener-
ates a weak phenotype in axon branches and does not affect the
axon elongation of sympathetic neurons in vitro (Strakova et al.,
2011). The role of PL synthesis in axon regeneration especially
in vivo has remained elusive. If lipin1 depletion promotes regen-
eration by redirecting TG synthesis to PL synthesis in neurons,
we reasoned that we must evaluate the function of PL synthesis
in axon regrowth more extensively.
We therefore assessed the role of PL synthesis in axon regen-
eration induced by lipin1 depletion. We focused on the Kennedy
pathway, the major biosynthetic pathway for de novo synthesis
of PC and PE (Figure 6A) (Gibellini and Smith, 2010). The rate-
limiting enzymes in the Kennedy pathway are CTP:phosphocho-
line cytidylyltransferase a (encoded by Pcyt1a), CTP:phospho-
choline cytidylyltransferase b (encoded by Pcyt1b) for PC, and
CTP:phosphoethanolamine cytidylyltransferase (encoded by
Pcyt2) for PE. Several non-rate-limiting enzymes are also
involved in PC synthesis, including Chka encoding choline ki-
nase a, Chkb encoding choline kinase b, and Pemt encoding
phosphatidylethanolamine N-methyltransferase. We tested the
function of each enzyme in axon regrowth using shRNAs against
Pcyt1a (shPcyt1), Pcyt1b (shPcyt1b), Pcyt2 (shPcyt2), Chka
(shChka), Chkb (shChkb), and Pemt (shPemt) both in vitro and
in vivo. In DRG neurons, none of the tested shRNAs had an
evident effect on axon elongation in WT neurons (Figures S6A
and S6B). Interestingly, axon growth enhanced by lipin1 shRNA
was completely reversed by Pcyt1b or Pcyt2 KD but not by
Pcyt1a or Chka KD (Figures 6B and 6C). In the optic nerve injury
model, we did not find a significant effect of any individual shRNA
in WT mice (Figure S6C). In mice with lipin1 depletion, Pcyt1b,
Pcyt2, or Chkb KD almost completely blocked the enhanced
axon regeneration (Figures 6D and 6E). Pcyt1a and Chka shRNA
partially suppressed the regrowth (Figures 6D and 6E), whereas
Pemt shRNA did not affect regeneration (Figures 6D and 6E).
RGC survival was not affected by KD (Figure S6D). In mice
with Dgat1 KO in RGCs, Pcyt1a, Pcyt1b, Pcyt2, or Chkb KD
significantly inhibited the axon regeneration (Figure S6E). We
further examined whether PC synthesis affects axon regenera-
tion more generally. In mice with AAV-CNTF injection into the
eyes or Pten deletion in RGCs, Pcyt1b KD significantly sup-
pressed the axon regeneration of the optic nerves (Figures S6F
and S6G). These results suggest that PC and PE synthesis medi-
ated by the Kennedy pathway is indispensable to axon
regeneration.
For the gain-of-function experiments, we assessed whether
stimulating PL production by overexpressing Pcyt1a, Pcyt1b,
and Pcyt2 in RGCs promotes axon regeneration. For Pcyt1a,(G and H) Levels of total TGs (G) or PCs (H) normalized to the total protein from
Dunnett’s test, n = 6.
(I) Quantification of regenerated axons in injured optic nerves from Rosa26-Cas9
control or Atgl shRNA. Shown are numbers of regenerating axons at the indicated
n = 6 mice. Error bars indicate SEM.
See also Figure S5.
10 Neuron 105, 1–17, January 22, 2020we also included constitutively active Pcyt1 (Pcyt1a-CA) by
removing the amphipathic C-terminal lipid-binding domain to
prevent autoinhibition of the enzyme catalytic activity (Craddock
et al., 2015). AAV carrying Pcyt1a, Pcyt1a-CA, Pcyt1b, or Pcyt2
was injected into the retinas of WT mice (Figure S6H), which
were subjected to optic nerve crush. Pcyt1a-CA and Pcyt2 over-
expression enhanced axon regeneration at 2 weeks after injury
(Figures 6F and 6G). Collectively, our results demonstrate that
PL biosynthesis plays an essential role in axon regeneration
induced by lipin1 depletion.
We have shown that aRGCs preferentially regenerate their
axons after lipin1 KD (Figure S2E). To test the hypothesis that se-
lective lipin1 upregulation in aRGCs after injury may inhibit the
axon regeneration by increasing TGs and decreasing PLs, we
compared the mRNA levels of Atgl, Pcyt1a, and Pcyt1b in WT
aRGCs and M1–M3 ipRGCs. In Opn4-GFP mice with sham or
optic nerve injury, we injected micro-Ruby into the optic nerve
to label RGCs. Under the fluorescencemicroscope, wemanually
isolated RGCs labeled by micro-Ruby or GFP after retina disso-
ciation and did single-cell qRT-PCR. RGCs with high Spp1
expression were regarded as aRGCs (Duan et al., 2015). GFP
was used to mark M1–M3 ipRGCs. We found that Atgl and
Pcyt2 were selectively downregulated in aRGC but not in
M1–M3 ipRGC (Figure S6I). The results support that the glycer-
olipid metabolism is selectively regulated in RGCs after injury
and mediates the axon regeneration.
TG Synthesis Inhibition Mediates Peripheral Axon
Regeneration
As the PNS neurons spontaneously regenerate their axons and
possess a stronger growth capacity than CNS neurons (Chan-
dran et al., 2016), we examined how the glycerol phosphate
pathway is regulated in adult DRG neurons in vivo. Three days af-
ter sciatic nerve injury in adult WT mice, we performed immuno-
staining to examine the levels of lipin1 and DGAT1 proteins in
DRG neurons. Lipin1 protein was detected in most neurons,
and the level was maintained after injury (Figure S7A). KD lipin1
in DRG neurons did not significantly enhance the spontaneous
axon regeneration at 3 days after sciatic nerve crush (Figures
S7B–S7D). DGAT1was found in both neuronal and non-neuronal
cells. In contrast to the injury-induced DGAT1 upregulation
observed in RGCs, the level of neuronal DGAT1 was significantly
decreased at 3 days after injury (Figure 7A). The percentage of
DGAT1+ DRG neurons was reduced by 50% compared with
sham control (Figure 7B). The staining of non-neuronal cells
did not change obviously. This downregulation was not merely
correlative because we have already shown that both DGAT1 in-
hibitors and KD can enhance DRG axon elongation in vitro (Fig-
ures S5A–S5D). Because our hypothesis was that DGAT1 down-
regulation inhibits TG synthesis and directs TG-derived DGs to
PL synthesis, we further examined the role of TG hydrolysis ineither Ctrl or Dgat1-shRNA group. **p% 0.01, *p% 0.05, ANOVA followed by
mice injected with AAV-Dgat1 or Dgat2-sgRNA at 2 WPI, combined with AAV-
distances distal to the lesion site. **p% 0.01, ANOVA followed by Tukey’s test,
(legend on next page)
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https://doi.org/10.1016/j.neuron.2019.10.009DRG axon regeneration in vitro and in vivo. In dissociated pri-
mary DRG neuron culture, TG lipase inhibitors—Atglistatin and
KLH-45—significantly inhibited axon elongation (Figures 7C
and 7D). Consistently, Ddhd2 KD in isolated DRG neurons sup-
pressed axon elongation in culture, and as a positive control
lipin1 KD increased the axon length (Figure S7E). Then, we sys-
tematically administered vehicle, KLH-45, or KLH-45 combined
with Atglistatin into WT mice, crushed the sciatic nerve, and
allowed the sensory axons to regrow for 2 days before examina-
tion (Figure S7F). SCG10 was used as a marker to specifically
label the regenerated sensory axons in the sciatic nerve as pre-
viously described (Chen et al., 2017; Shin et al., 2014). In the con-
trol mice, sensory axons robustly regenerated several hundred
micrometers within 2 days. This spontaneous regeneration was
modestly inhibited by KLH-45 alone and markedly suppressed
by the combination of KLH-45 and Atglistatin (Figures 7E and
7F). Neuronal survival was not affected by the compounds (Fig-
ure S7G). The results demonstrate that TG hydrolysis is required
for peripheral axon regeneration. The differential regulation of the
glycerol phosphate pathway in injured PNS and CNS neurons
may contribute to the different regenerative capabilities.
DISCUSSION
Our study reveals a critical role of the neuronal glycerolipid
biosynthesis pathway in response to injuries and axon regener-
ation. Previous studies have demonstrated that successful
regeneration in neurons requires activation of proregenerative
transcription and translation (Cho et al., 2015; Moore et al.,
2009; Park et al., 2008; Sun et al., 2011; Terenzio et al.,
2018), epigenetic regulation (Cho et al., 2013; Gaub et al.,
2010; Oh et al., 2018; Rivieccio et al., 2009; Weng et al.,
2017, 2018), cytoskeletal dynamics and transport (Blanquie
and Bradke, 2018; Hellal et al., 2011; Nawabi et al., 2015), mito-
chondrial mobility and localization (Cartoni et al., 2016; Luo
et al., 2016; Zhou et al., 2016), among other processes. Our
findings indicate that neuronal lipid metabolism also needs to
be properly coordinated for injured axons to regenerate. We
propose a model in which axotomy disrupts the homeostatic
synthesis of glycerolipids in the glycerol phosphate pathway
by increasing lipin1 and DGAT1 and limits axon regeneration
in CNS neurons by directing the lipid flux toward energy storage
rather than membrane extension (Figure 7G). Forced lipin1
depletion reduces the supply for TG production on the one
hand and upregulates PA on the other hand, which may stimu-Figure 6. PL Biosynthesis Is Essential for the Axon Regeneration Indu
(A) Schematic showing the PL synthesis pathways in mammals.
(B) Representative images of replated neurons from the respective groupswith Tuj
shRNA for 10 days. Neurons were then replated and fixed 24 h later. DRG neurit
(C) Quantification of the length of the longest axon for each DRG neuron in (B).
**p% 0.01, ANOVA followed by Tukey’s test.
(D) Sections of optic nerves from Cas9mice at 2WPI. The vitreous body was inject
(E) Number of regenerating axons at the indicated distances distal to the lesion s
(F) Sections of optic nerves from WT mice at 2 WPI. The vitreous body was injec
FITC. Scale bar: 100 mm.
(G) Number of regenerating axons at the indicated distances distal to the lesion
**p% 0.01, ANOVA followed by Tukey’s test, n = 6 mice. Error bars indicate SEM
See also Figure S6.
12 Neuron 105, 1–17, January 22, 2020late PCYT1 activity and subsequent PL synthesis. In addition,
active TG hydrolysis generates a supply of DGs as the precur-
sor for PLs. DGAT1 depletion may suppress TG production and
drive DGs to the Kennedy pathway, a strategy adopted by pe-
ripheral neurons for axon regeneration. It is also possible that
released free fatty acids from TG hydrolysismay also contribute
to the lipid precursor supply through early reaction steps of the
glycerol 3-phosphate pathway. Taken together, our model
stresses that the balanced synthesis between TGs for storing
energy and PLs for building membranes may determine the
axon regeneration competence.
Several lines of evidence support our working hypotheses.
First, lipin1 depletion promoted axon regeneration after optic
nerve crush and decreased TGs while increasing PLs in neu-
rons. Directly suppressing de novo synthesis of TG by KD
Dgat also boosted axon growth and the PL level. Second, the
changes in TG and PL levels were more than correlation
because either forcing TG storage or inhibiting PL synthesis en-
zymes almost completely blocked lipin1- and Dgat1-depen-
dent axon regeneration in vivo. Third, lipin1 level was reduced
in regenerating RGCs induced by either Pten KO or CNTF,
two independent mechanisms mediating axon regeneration
(Sun et al., 2011). Fourth, either Atgl KD or Pcyt1b KD sup-
pressed Pten KO and CNTF-induced axon regeneration. Fifth,
in PNS neurons that spontaneously regenerate their axons,
DGAT1 was downregulated upon axotomy, suggesting that
the glycerol phosphate pathway is actively involved in periph-
eral axon regeneration by shifting lipid storage toward mem-
brane lipid production. Indeed, TG hydrolysis is required for
sensory axon regeneration after sciatic nerve crush, indicating
that this lipid metabolic pathway affects adult axon regenera-
tion more broadly.
In the plant, Arabidopsis thaliana, double mutation of pah1 and
pah2 (homologs of mammalian lipin) increases the level of PLs
with massive membrane expansion via increased transcription
of several PL synthesis genes (Craddock et al., 2015). Studies
in yeast show that loss of smp2 (a homolog of mammalian lipin)
promotes the transcription of PL synthesis genes and leads to
nuclear membrane expansion (Santos-Rosa et al., 2005). In
addition, depleting the PAP activity in rodent enterocytes in-
creases the PC level by increasing PCYT1A protein. It is likely
that diminished PAP activity induces PA accumulation, which
enhances PCYT1A and possibly other enzymes (Zhang et al.,
2019). Inmouse neurons, lipin1 depletion likely promotes PL syn-
thesis through a similar mechanism.ced by lipin1 Depletion
1 staining. Adult DRG neuronswere dissociated and culturedwith different AAV
es were visualized by Tuj1 staining. Scale bar: 400 mm.
Three mice and 10–20 cells from each mouse were quantified in each group.
ed with respective AAVs. Axons were labeled by CTB-FITC. Scale bar: 100 mm.
ite. **p% 0.01, ANOVA followed by Tukey’s test, n = 6 mice.
ted with AAV-GFP, Pcyt1a, Pcyt1a-CA, or Pcyt2. Axons were labeled by CTB-
site.
.
Figure 7. TG Synthesis Inhibition Promotes Spontaneous Peripheral Axon Regeneration
(A) DRG sections from WT animals 3 days after sciatic nerve crush or sham surgery, stained with Tuj1 (green) or DGAT1 (red) antibodies. Scale bar: 100 mm.
Zoomed-in images are shown in the right panel. Scale bar: 20 mm.
(B) Percentage of DGAT1+ DRG neurons in (A). **p% 0.01, Student’s t test.
(C) Representative images of DRGneurons in primary cultures treatedwith DMSO vehicle, Atglistatin (10 mM), or KLH-45 (10 mM). DRG neurites were visualized by
Tuj1 staining. Scale bar: 400 mm.
(D) Quantification of the length of the longest axon for each DRG neuron in (C). Three mice and 10–20 cells from each mouse were quantified in each group.
**p% 0.01, ANOVA followed by Dunnett’s test.
(legend continued on next page)
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https://doi.org/10.1016/j.neuron.2019.10.009The glycerol phosphate pathway regulates the synthesis of
glycerolipids at different growth stages or upon stress. In yeast,
membrane lipids are preferentially synthesized from the precur-
sor PA during exponential growth. When cells progress to the
stationary phase upon nutrients exhaustion, PA is directed to-
ward TG synthesis. In metabolic cells, the TG represents thema-
jor neutral lipids stored in cells and excessively synthesized TGs
mainly exist in lipid droplets. The incorporation of synthesized
TGs into lipid droplets is a protective mechanism under certain
stress conditions. This mechanism can prevent the accumula-
tion of unesterified lipids that may trigger inflammatory re-
sponses and cause lipotoxicity in cells. In our study, axonal injury
enhanced lipin1 levels in RGCs, which may have increased TG
synthesis. This could be a protective response from RGCs,
although it is unclear whether any neuronal lipid droplets were
formed. It is challenging to identify neuronal LDs that are rare
or transient. Interestingly, in axotomized adult rabbit vagal neu-
rons that regenerate their axons poorly, lipid accumulation can
be detected by electron microscopy (Aldskogius, 1978). In other
cases, lipid droplets can be detected in axons of Aplysia, neu-
rons in the Huntington’s disease model, and cortical neurons in
culture (Welte, 2015). In the adult mouse brain, LDs are rarely
found. But they can accumulate inside neurons of Ddhd2 KO
mice and also in adult DRG neurons when TG lipase inhibitors
were added in culture as shown in our study. The physiological
role of constant and quick turnover of TG inside adult neurons
is not entirely clear. Our data suggest that it may be related to
supplying membrane lipids. Under injury conditions, it may
contribute to rebuild axons, whereas, under naive conditions, it
may be involved in supplying membrane structures such as
various vesicles, crucial for maintaining normal neuronal func-
tions. However, we cannot exclude the possibility that other
functions of PLs may contribute to the growth effect. Further
studies will be necessary to elucidate the functional role of TG
hydrolysis in neurons.
The endoplasmic reticulum (ER) is the largest organelle and
forms a continuous network throughout the neuron including
the axon (Gonza´lez et al., 2016; Wu et al., 2017). The ER mem-
brane is a major site of lipid biosynthesis, including TG, PC,
and PE synthesis, and houses many of the enzymes involved
(Zhang and Reue, 2017). Axonal injury inevitably causes dam-
ages to the tubular ER in the axons. In addition, optic nerve injury
induces ER stress in RGCs (Hu et al., 2012). Previous studies
suggest that the expression of one of the lipin family members,
lipin2, is induced by ER stress in liver cells (Ryu et al., 2011).
Thus, axotomy-induced ER stress in neurons may also affect
lipid synthesis through regulating lipin. This warrants a future
study on the relationship between axon injury, ER stress, and
lipid metabolic changes.(E) Sections of sciatic nerves from WT animals treated with DMSO, KLH-45, or
Scale bar: 400 mm.
(F) Quantification of regenerating sensory axons in (E). **p% 0.01, *p% 0.05, AN
(G) A working model of the glycerol phosphate pathway in axon regeneration b
regenerating neurons. TG and PL metabolism maintains homeostasis in intact n
accumulation in neurons and eventually inhibits axon regeneration. However, after
axon regeneration.
See also Figure S7.
14 Neuron 105, 1–17, January 22, 2020Lipin1 mutant mice have lipodystrophy with significant reduc-
tion in fat mass and other pathological defects, which makes
lipin1 a non-ideal translational target. DGAT2 is essential for sur-
vival in mice (Stone et al., 2004). However, Dgat1 KO mice are
viable, generally lean, and resistant to diet-induced obesity
(Smith et al., 2000). DGAT1 has emerged as an attractive drug-
gable target for certain metabolic disorders (Chen and Farese,
2005; DeVita and Pinto, 2013). Further studies should investigate
whether local or systematic inhibition of DGAT1 can achieve a
similar growth effect to that of the genetic KO in a clinically rele-
vant injury model such as spinal cord injury. In summary, our re-
sults demonstrate a potentially translatable strategy, which in-
volves tailoring glycerolipid synthesis in support of axon
regeneration.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Wild-type (WT, C57BL/6J, Charles River) mice of both genders at P1, P7, P21 or P50 were used in experiments of examining the lipin1
levels in RGCs by aging. In all the other experiments, wild-type and transgenic mice of both genders (7-8 weeks old) were used as indi-
cated. Constitutive SpCas9 knockin mice (stock number: JAX_026179) (Platt et al., 2014) were obtained from Jackson Laboratories.Neuron 105, 1–17.e1–e5, January 22, 2020 e2
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https://doi.org/10.1016/j.neuron.2019.10.009Opn4-GFPmice (Li et al., 2016) were obtained from theMutant Mouse Regional Resource Center, an NIH funded strain repository, and
the strain was donated by the National Institute of Neurological Disorders and Stroke funded Gene Expression Nervous System Atlas
(GENSAT) bacterial artificial chromosome (BAC) transgenic project. Pten-floxedmice (Park et al., 2008) were gifts from Dr. Zhigang He
(Boston Children’s Hospital). Housing and breeding conditions followed standard procedures. Experimental and control mice were lit-
termates andwere kept together before experiments. All experimental procedures were performed in compliancewith animal protocols
that were approved by the Animal and Plant Care Facility at the Hong Kong University of Science and Technology.
Cell lines
Neuro2A cells (ATCC, stock number: CCL-131) were maintained at 37C under a humidified 5%CO2 atmosphere using Dulbecco
Modified Eagle Medium (DMEM) and supplemented with fetal bovine serum (HyClone).To test the KD efficiency of shRNAs, Neuro2A
cells were first cultured on a 12-well plate to 70%–80%confluency. Cells were then transfectedwith 1 mg shRNAplasmid by Lipofect-
amine 3000 for 48 h. The transfection procedure was performed according to the manufacturer’s protocol.
Primary cell cultures
DRG primary culture and replating were performed as previously described (Weng et al., 2018). In brief, for primary culture, L4-L6
DRGs from 7-8 weeks wild-type mice of both genders were dissected and then digested in 0.5% collagenase for 1.5 h. After termi-
nation of digestion, DRGs are pipetted 20-30 times in a tube for complete dissociation. Neurobasal-A with B27 as a supplement was
used as a medium for DRG culture. Virus was added at 1 day in vitro (DIV1) for genetic manipulation. Atglistatin (10 mM), KLH-45
(1 mM), paradigastat (1 mM) or A-922500 (500 nM) treatment was used for ATGL, DDHD2 or DGAT1 inhibition.
For replating DRG neuron culture, at DIV9-11 of primary DRG culture, cells were gently pipetted on culture dishes. Usually, cells
were flushed by 20-30 rounds of pipetting in eachwell of a 6-well plate. After all the cells were resuspended, theywere replated onto a
24-well plate. Fixation and staining were performed 24 h after replating. Tuj1 staining was used to visualize axons and cell bodies of
neurons. The lengths of the longest neurites from each DRG neuron weremeasuredmanually by NeuronJ in ImageJ. Average lengths
of 10-20 neurites from 3 individual mice were used in each group.
For the in vitro screening, dissociated DRG neurons from 4-6 DRGs were first resuspended in 100 mL Amaxa mouse neuron elec-
troporation buffer (Lonza) containing 5 mg respective plasmids. The cell suspension was then transferred to 2mm cuvette (Lonza) for
electroporation. The electroporation was done by using the Amaxa Nucleofector System (Lonza). The primary culture and replating
procedures were described as above.
Cortical neurons were isolated from E18 mouse embryo. Briefly, the cortex from E18 C57/B6 mice of both genders was dissected
and digested in 0.5 mg/mL papain for 30 min. Then, 100 mL fetal bovine serum (HyClone) was added to inactivate papain. The cells
were then placed into Neurobasal medium (GIBCO), supplemented with B27 (GIBCO) and 1% penicillin-streptomycin (10,000 U/mL;
GIBCO). AraC (100 nM; Sigma) was used to inhibit glial proliferation in DIV1-DIV3. After 10 days of culture with AAV-scramble, AAV-
shLipin1, AAV-shDgat1 or AAV-shDgat2, cells were harvested, and then TG or PC levels were measured according to the manufac-
turer’s protocol (ab65336 and ab83377).
METHOD DETAILS
AAV construct and packaging
AAV serotype 2/1 was used for CNTF overexpression. AAV serotype 2/2 was used for all the other overexpression and shRNA AAVs.
The AAV construct backbone for overexpression and shRNAswas obtained fromPenn Vector Core. qRT-PCRwas used for virus titer
measurement. The virus titer was 1013 GC/mL.
Western blot
For western blot analysis, cells were harvested in ice-cold PBS and then lysed in RIPA buffer for 45 min. RIPA buffer consisted of
50 mM Tris$HCl at pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% Na-deoxycholate, 0.5% SDS supplemented with EDTA-free
cOmplete ULTRA tablets (Roche), and PhosSTOP Complete Easypack (Roche). Cell lysates were centrifuged at 16000 g for
10 min. 4x SDS sample buffer was added to the supernatant of cell lysates. Western blotting was performed according to the
standard protocol.
Genomic DNA extraction and T7E1 assay
To validate the efficiency of sgRNAs, Neuro2A cells were first cultured on a 12-well plate to 70%–80% confluency using Dulbecco
Modified EagleMedium (DMEM) and supplemented with fetal bovine serum (HyClone). Cells were then transfected with 1 mg SpCas9
and respective sgRNA plasmid by Lipofectamine 3000 for 72 h. Genomic DNA of Neuro2A was purified by PureLink Genomic DNA
Mini Kit. The amplification of target DNA fragment and efficiency testing of individual sgRNAs were performed with manufacturer’s
protocol of NEB T7 Endonuclease I. Primers used for DNA fragment amplification were listed in STARMethods. In brief, purified PCR
product was denatured and then annealed. If indels existed in the PCR product, heteroduplex DNA would form after annealing. Then
T7 Endonuclease 1 was added to recognize and cleave theheteroduplex DNA at the mismatching site. Finally, we used gel electro-
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Intravitreous injection and optic nerve injury were performed as previously described. Mice were intravitreously injected with AAV at
postnatal day 28 (P28)-P42. In brief, mice were anesthetized by a mixture of ketamine (80 mg/kg) and xylazine (10 mg/kg). We
clamped the edge of the eyelid with a small artery clamp to expose the conjunctiva. Two microliters of virus was injected gently
into each vitreous body using a Hamilton syringe. Meloxicam (1 mg/kg) was injected as analgesia after the operation. Mice with
obvious eye inflammation or shrinkage were sacrificed and excluded from further experiments.
Four weeks after virus injection, intraorbital optic nerve crush was performed as previously reported. After the mice were
anesthetized and an incision was made on the conjunctiva, the optic nerve was crushed by jeweler’s forceps (Dumont #5; Fine
Science Tools) for 2 s at 1-2 mm behind the optic disk. To visualize regenerating axons, RGC axons in the optic nerve were
anterogradely labeled by 1.5 mL CTB (2 mg/mL, Invitrogen) 12 days after injury.
Whole-mount Tuj1 staining was used to determine the number of surviving RGCs at two weeks after optic nerve crush. The retina
was dissected and stained following the previous protocol. Briefly, the retina was washed with 1X PBS three times in a 24-well plate
and then incubated with PBSwith 4%normal goat serum (NGS) for 30mins. After incubation with the Tuj1 antibody overnight at room
temperature, the retinawaswashedwith PBS three times and incubatedwith secondary antibody for 1 h. After the tissuewaswashed
with PBS, the retina was mounted onto glass slides, and images were taken under a confocal microscope (Zeiss, LSMMeta710; 40X
and 63X objective). For each retina, 12 images were taken fromdifferent quarters, which covered the peripheral and central regions of
the retina. An individual who was blind to different groups counted the number of Tuj1+ RGCs.
To quantify the number of CTB-FITC-traced axons after optic nerve crush, the optic nerve was dissected carefully and placed
longitudinally for cryo-section (section thickness: t = 8 mm). The serially collected optic nerve tissue was stained with the FITC anti-
body, mounted onto glass slides and imaged under a confocal microscope (Zeiss, LSM Meta710; 10X objective). Captured images
were stitched together by using ImageJ. The images of optic nerve with CTB channel were converted into red and exported.
Representative optic nerves were cropped from the stitched images. This process may leave some dashed lines or uneven back-
ground around the optic nerve. Five images were taken for each optic nerve. The following formula was used to quantify the number
of regenerated axons at different distances from the lesion site:
P
ad = pr23 [average axon numbers/mm]/t. The r is the radius of the
optic nerve at the counting site, and the average axon numbers/mm were determined by the average numbers of (axon numbers) /
(nerve width at the counting site) of the five sections. The t is the section thickness (8 mm). Axon numbers were counted by an indi-
vidual who was blind to different groups.
Retrograde Labeling of Regenerating RGCs
At thirteen days after the optic nerve crush, mice were anesthetized and placed in a stereotaxic holder. The crushed optic nerve was
gently exposed, with a pulled-glass micropipette attached to a Hamilton syringe, we slowly injected FG (100 nL, 5% wt/vol) into the
optic nerve 2 mm distal to the lesion site. 1 day later, the animals were sacrificed and the retinas were dissected for staining.
RGC isolation and qRT-PCR
For isolating single RGCs bymouth-pipetting, 8 weeks old Opn4-GFPmice received an optic nerve crush or sham injury, thenmicro-
Ruby (500 nL, 5%wt/vol. Invitrogen) was slowly injected into the optic nerve. 3 days later, the animals were sacrificed and the retinas
were dissected and digested in 0.5 mg/mL papain for 35 min. Then, fetal bovine serum (HyClone) was added to stop the digestion.
After centrifugation, the cells were then suspended into Neurobasal medium for further dissociated into single cell suspensions. With
a mouth pipette, GFP positive cells or micro-Ruby positive (red) cells were gently pipetted into a new medium drop, after several
times repeating, one cell was pipetting into a tube containing lysis buffer. The cell lysis, RT-PCR and pre-amplification were per-
formed with previously described smart-seq2 protocol (Picelli et al., 2014). Pre-amplified cDNAwas used as templates for qRT-PCR.
For isolating GFP or mCherry positive RGCs by FACS, the dissociation was done by the above procedure. Cell sorting was per-
formed with BD FACSAria III instrument. Dissociated retinal cells were separated based on size (forward scatter) and surface char-
acteristics (side scatter) as well as viability (DAPI staining). Doublets or clots were excluded based on the FSC-H-versus-FSC-A ratio.
Retinal cells from control mice without any virus injection were used to set up gates for each experiment. 5000 sorted cells were
collected in each replicate and RNA was extracted by RNeasy Mini Kit (QIAGEN). Total RNA was reverse transcribed to cDNA by
SuperScript II Reverse Transcriptase using manufacturer’s protocol.
For qRT-PCR, each sample was run in 2-4 replicates. Gapdh was used as endogenous control. The qRT-PCR was done by man-
ufacturer’s protocol of LightCycler 480 SYBR Green I Master.
Intrathecal injection of AAVs
AAV1-control or lipin1 shRNA was injected to thecal sac between L5 and L6. Briefly, mice were anesthetized with a mixture of
ketamine (80 mg/kg) and xylazine (10 mg/kg). An incision was conducted in themiddle line. Then dura was exposed by laminectomy.
A microforged glass needle was inserted into the median area and 3 mL virus was slowly infused to the spinal cord. The skin was
sutured with stainless clip and the mice were placed on heating pad until awake. The sciatic nerve crush was done 4 weeks after
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KLH-45 (30mg/kg/day) or Atglistatin (40mg/kg/day) were delivered by intraperitoneal injection for consecutive 5 days before injury
and 2 days after injury. Same dosage of DMSO injection was used as control treatment. Sciatic nerve injury was performed as pre-
viously described. Briefly, after an incision wasmade on the skin at the middle thigh level, muscle was gently dissected to expose the
sciatic nerve. Then, the sciatic nervewas crushed for 10 s by forceps (Dumont #2; Fine Science Tools). For the shamgroup, the sciatic
nerve was only exposed but not crushed.
Sciatic nerve sections with SCG10 staining were used to quantify the regeneration index. A column with a width of 50 pixels was
drawn at different distances from the lesion center, and the average intensity of SCG10 staining was measured using ImageJ. The
distance between the lesion center and the column with half the intensity of the lesion center was considered as the regenera-
tion index.
Immunohistochemistry
For BODIPY staining on cultured DRG neurons, cells were first fixed in 4% PFA for 10 min and permeabilized with 0.1% Triton X-100
in 4% NGS. After cells were blocked, the Tuj1 antibody was applied in blocking buffer and incubated at 4C overnight. Coverslips
were thenwashed three timeswith PBS and incubated with secondary antibodies at room temperature for 2 h. Cells were finally incu-
bated with 200 nM BODIPY (Sigma) in blocking buffer for 30 min before mounting.
For immunostaining of tissue sections, mice were first given a lethal dose of anesthesia and perfused with PBS followed by 4%
PFA. Retinas, optic nerves or DRGs were dissected and postfixed in 4%PFA for 2 h. Tissue was cryoprotected in 30% sucrose over-
night and then embedded into OCT compound (Tissue-Tek) at80C. Samples were sectioned at20C (20 mm for retina and 8 mm
for nerve andDRG). Tissue sectionswere then blocked and permeabilizedwith 0.1%Triton X-100 in 4%NGS. After the samples were
blocked, they were incubated in primary antibody diluted by blocking buffer overnight. After the samples were washed 3 times with
PBS, the corresponding secondary antibody diluted by blocking buffer was applied. After the samples were mounted on coverslips,
they were imaged under a confocal or epifluorescence (Nikon, TE2000) microscope.
Lipid extraction and UPLC-MS
Lipid extraction was performed using the Folch method. Cortical neurons were lysed in a 2:1 chloroform:methanol mixture. After the
upper phase was siphoned, the solvent was dried by line blowing with nitrogen. Lipid extracts were analyzed using a Synapt G2
HDMS mass spectrometer coupled with an ACQUITY UPLC system (Waters, Milford, USA). The UPLC separation was carried out
using a Charge Surface Hybrid column (particle size: 1.7 mm; length: 100 mm; i.d.: 2.1 mm). The mobile phase consisted of solvent
A (0.1% formic acid in water, v/v) and solvent B (0.1% formic acid in acetonitrile, v/v), each with 10 mM ammonium acetate. The
elution gradient conditions were as follows: 0 min, 40% B; 2 min, 43% B; 2-2.1 min, 50% B; 12 min, 54% B; 12.1 min, 70% B;
12.1-18 min, 99% B. The flow rate was 0.2 mL min-1, and the injection volume was 2 mL. A two minutes post-run time was set to fully
equilibrate the column. Column temperature and sample chamber temperature were set to 55C and 6C, respectively. The source
parameters were set as follows: source temperature, 90C; desolvation temperature, 400C; core gas flow, 20 L h-1; cone voltage, 40
V; capillary voltage, 3 kV and 2.5 kV in positive and negative ion modes, respectively. The mass range was set as 50 – 1200 Da. The
collision energy was set as 40 V. Individual lipid species were semiquantified by referencing to spiked internal standards obtained
from Avanti Polar Lipids (Alabaster, AL), i.e., PC (16:0-d31/18:1) and TG (16:0/18:0/16:0-d5).
Raw UPLC-ESI-MS data were directly imported to the Progenesis QI software (Waters-Nonlinear) for data processing, including
peak picking, alignment (retention time correction), and data normalization. The processed data matrices were imported to the IBM
SPSS Statistics software (Version 11.0, SPSS Inc., Chicago, IL, USA) for t test analysis. The m/z values of ions with p value < 0.05
were further exported to the SIMCA 14.1 software for OPLS-DA. From the OPLS-DA, ions with VIPR 1 and fold change between
different groups > 1.5 were considered as potential biomarkers and were subjected to identification using a database (LIPIDMAPS,
Metlin, LipidBlast and HMDB) and MS/MS fragmentation.
QUANTIFICATION AND STATISTICAL ANALYSIS
The number of animals or repeats is described in figure legends. All analyses were conducted using Prism 6 software (GraphPad
Software, La Jolla, CA). Student’s t test was used for two-group comparisons, and ANOVA was used for multi-group comparisons.
An estimate of variation in each group is indicated by the standard error of mean (SEM). ** p% 0.01, * p% 0.05.
DATA AND CODE AVAILABILITY
This study did not generate any code. The data that support the findings of this study are available from the Lead Contact upon
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